Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer

Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer

Abstract Background Head and neck squamous cell carcinoma (SCC) is one of the most prevalent and deadly cancers worldwide. Even though surgical approaches, radiation therapy, and therapeutic agents are commonly used, the prognosis of this cancer remains poor, with a tendency towards recurrence and m...

Full description

Bibliographic Details
Main Authors: Alberto Juan, Carmen Segrelles, Almudena del Campo-Balguerías, Iván Bravo, Ignacio Silva, Jorge Peral, Alberto Ocaña, Pilar Clemente-Casares, Carlos Alonso-Moreno, Corina Lorz
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cancer Nanotechnology
Subjects:
Polymeric nanoparticles
PI3K inhibitors
EGFR
Head and neck cancer
Cancer therapy
In vivo imaging
Online Access:https://doi.org/10.1186/s12645-023-00180-z

Internet

https://doi.org/10.1186/s12645-023-00180-z

Similar Items